Business
Lilly takes 6 companies to court for selling retatrutide knockoffs - Fierce Pharma
What the report says
Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. | Eli Lilly has filed lawsuits against six U.S. companies, accusing them of selling illegal versions of its experimental weight-loss drug retatrutide.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Amule: Uganda Needs Stronger Marketing to Win More French TouristsDokolo Post
YOUR LEGACY LIGHTS THE PATH”: SSEKANDI SALUTES MUSEVENI ON HIS BIRTHDAYWatchdog Uganda
WHAT NEXT FOR SHAKIRA OKOOBAH? MISS TOURISM EAST AFRICA FIRST RUNNER-UP SETS HER SIGHTS ON COMMUNITY CHANGEWatchdog Uganda
Equity Group roadshow seeks to unlock cross-border trade and investmentNile Post
Prince Edward Rukidi Nyabongo I to Be Crowned Tooro King on September 29Watchdog Uganda